baber/WOPTO huggingface dataset:
Patent PT-1739259-E (PT)
Title: Handle for a vehicle part
Inventor: MIDDEL DIETMAR
IPC: E05B65/20
Filed: 2005-12-16
Abstract: The component has clearance cracks (3.8, 3.9) between long edges of an operation part (3.2). The crack (3.8) between a frame part (3.1) and one of the edges is greater than the crack (3.9) between the part (3.1) and the other edge, so that the part (3.2) is turned around a swiveling axis (3.6) during the actuation of the part (3.2). The axis runs through the crack (3.9) that is arranged between one of the edges and the part (3.1).
Patent PT-1597286-E (PT)
Title: Polyolefin production using high olefin concentration
Inventor: CONTI GIACOMO
IPC: C08F210/16
Filed: 2005-02-08
Abstract: Provided is an apparatus for polymerising an olefin monomer, which apparatus comprises the following:  (a) a reactor for polymerising the olefin monomer; (b) a means for measuring the presence of gas in the reactor; and (c) a means for controlling the concentration of olefin monomer in the reactor;  wherein, the means for measuring the presence of gas in the reactor is a means capable of measuring a pressure curve in the reactor to determine whether the pressure curve is characteristic of a hydraulic system or a non-hydraulic system. <IMAGE>
Patent PT-1829387-E (PT)
Title: Cable connector for printed circuit boards
Inventor: KLEIN HARALD
IPC: H01T4/06
Filed: 2005-11-03
Abstract: A cable connector (1) for printed circuit boards includes a housing (2, 3) and at least two contact elements (4). Each contact element includes a contact (11) for connecting electrical wires and a fork contact (6, 7) for making contact with a printed circuit board. A surge arrester (17) is arranged within the housing (2, 3) and is arranged electrically between the contact elements (4).
Patent PT-1790728-E (PT)
Title: Imaging, diagnosis and treatment of disease
Inventor: HUMINIECKI LUKASZ
IPC: A61P9/00
Filed: 2001-11-06
Abstract: The present invention relates to endothelial cell-specific genes and encoded polypeptides and materials and uses thereof in the imaging, diagnosis and treatment of conditions involving the vascular endothelium.
Patent PT-2012763-E (PT)
Title: Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid
Inventor: BLOMS-FUNKE PETRA
IPC: A61K31/137
Filed: 2007-04-25
Abstract: A combination comprising as components (a) the compound 3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol, and (b) one or more non-steroidal anti-inflammatory drugs (NSAIDs); a pharmaceutical salt comprising said components; a compound derived from said components; a pharmaceutical formulation and a dosage form comprising said combination, salt, or compound; as well as a method of treating pain, e.g. chronic or acute pain, in a mammal characterized in that components (a) and (b) are administered simultaneously or sequentially to a mammal, wherein component (a) may be administered before or after component (b) and wherein components (a) or (b) are administered to the mammal either via the same or a different pathway of administration.
Patent PT-2053190-E (PT)
Title: Regulation mechanism for sliding doors
Inventor: LLORET MIGUEL ANGEL TARREGA
IPC: E05F5/00
Filed: 2008-10-20
Abstract: The invention relates to a regulation mechanism for built-in sliding doors of the type comprising a sliding leaf (4), a guide (6) in the lower part of said sliding leaf (4) and a fixed stop (16) inside said guide (6), comprising a cover (1) fixed at the end of the sliding leaf (4), a mobile stop (2) slidable through the inner part of the guide (6) situated between the cover (1) and the fixed stop (16), and an adjustment screw (3) traversing the cover (1) and the mobile stop (2) by means of which the relative position between both elements (1) and (2) is regulated.
Patent PT-2298769-E (PT)
Title: Xanthin derivatives, their production and utilisation as medicine
Inventor: MAIER ROLAND
IPC: A61P3/04
Filed: 2002-02-21
Abstract: 8-substituted-xanthine derivatives (I), their tautomers, enantiomers, diastereomers or mixtures, and salts. 8-substituted xanthine derivatives of formula (I), their tautomers, enantiomers, diastereomers or mixtures, and salts, are new: [Image] R1>hydrogen; 1-8C alkyl; 3-8C alkenyl or alkynyl; 3-4C alkenyl substituted by 1-2C alkoxycarbonyl, aminocarbonyl (optionally substituted by 1 or 2 1-3C alkyl) or het-CO; 1-6C alkyl substituted by Ra; phenyl(1-6C)alkyl, optionally ring-substituted by R1>0>-R1>4>; phenyl(1-4C)alkyl, optionally substituted in alkyl by Rz and in the ring by R1>0>-R1>4>; R1>0>-R1>4>-substituted phenyl; phenyl(2-3C) alkenyl, phenyl (or naphthyl)-(CH2)m-(A or B)-(CH2)n, naphthyl(1-3C)alkyl or phenylcarbonylmethyl (all optionally ring-substituted by R1>0>-R1>4>); [1,4-napththoquinon-2-yl; chromen-4-on-3-yl; 1-oxo- or 1,3-dioxo-indan-2-yl; 2,3-dihydro-3-oxo-benzofuran-2-yl; heteroaryl-(CH2)m-(A or B)-(CH2)n; 1-6C alkyl-A-(CH2)n; 3-7C cycloalkyl-(CH2)m-A or B)-(CH2)n; R2>1>-A-(CH2)n; phenyl- or naphthyl-(CH2)m-D-(1-3C)alkyl; Rb-substituted 2-6C alkyl, or 3-6C cycloalkyl; amino, or arylcarbonylamino; het : pyrrolidin-1-yl, piperidin-1-yl or morpholin-4-yl; R1>0>-R1>4>, Rb and Rz : various substituents; m : 0-2; n : 1-3; A, B and D : various linking groups; R2>hydrogen or a wide range of substituents; R3>various substituents; R4>a wide range of substituents. The full definitions are given in the DEFINITIONS (Full Definitions) Field. - ACTIVITY : Antidiabetic; antiarthritic; antiinflammatory; immunosuppressive; osteopathic; antilipemic; antiarteriosclerosis; anabolic; cardiant; nephrotropic; antinfertility. - MECHANISM OF ACTION : Inhibition of dipeptidylpeptidase-IV (DPPIV). The compound (R)-1,3-dimethyl-7-(3-methyl-2-buten-1-yl)-8-(3-aminopiperidin-1- yl)xanthine had IC50 against DDPIV expressed in Caco-2 cells of 22 nM.
Patent PT-665938-E (PT)
Inventor: DOUCET MICHEL
IPC: F23Q2/16
Filed: 1993-10-22
Abstract: A selectively actuatable lighter device (10) is disclosed which includes a body defining reservoir (12) for containing a combustible gaseous medium such as butane, and having a valve (20) arranged to be selectively actuated between a normally closed position and an open position which permits the exit of the gaseous medium. Such lighter (10) can selectively produce sparks at a location (19, 22) proximate to the gaseous medium exit to ignite the gaseous medium. Such lighter device (10) embodies a resiliently releasable valve actuator (14) which normally prevents actuation of the valve (22). The valve actuator (14) includes an interfering portion (14A) which is selectively movable to a position out of interference with an interfering portion (12B) of the lighter body, so that the gaseous medium may be released and ignited by the sparks. Once the valve actuator (14) is depressed and released, it returns to its closed or latched position to prevent actuation of the valve to the open position. To "re-use" the lighter, the valve actuator (14) must again be moved to an unlatched position so that the valve (22) can be actuated for subsequent ignition of the gaseous medium.
Patent PT-871476-E (PT)
Inventor: ROSER BRUCE JOSEPH
IPC: A61K35/14
Filed: 1996-01-19
Abstract: A stable blood factor composition contains a stabilising amount of trehalose in the absence of human serum albumin to provide a product stable at up to 60°C.
Patent PT-808163-E (PT)
Inventor: CERAMI ANTHONY
IPC: C07D277/38
Filed: 1996-01-18
Abstract: The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein aging). Accordingly, compositions are disclosed which comprise an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins, and which additionally reverse pre-formed crosslinks in the advanced glycosylation endproducts by cleaving alpha-dicarbonyl-based protein crosslinks present in the advanced glycosylation endproducts. Certain agents useful are thiazolium salts. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated. A novel immunoassay for detection of the reversal of the nonenzymatic crosslinking is also disclosed.
Patent PT-758928-E (PT)
Inventor: JONES DENNIS J
IPC: D06M15/263
Filed: 1996-02-09
Abstract: The invention is directed to a method and composition for treating carpet yarn and carpet to thereby enhance its repellency, and preferably to enhance its stain resistance as well. In one aspect of the invention, the method includes the steps of providing a carpet yarn comprising polymeric fibers. An anionic or nonionic fluorochemical compound is provided in an aqueous medium, the aqueous medium having a pH below about 3.5. The carpet yarn is immersed in the aqueous medium. The carpet yarn and aqueous medium are heated after which excess water is removed from the carpet yarn. The aqueous medium preferably also includes an anionic binding compound that acts to impart stain resistance to the yarn.
Patent PT-881899-E (PT)
Inventor: ASHLEY PRICE IAN
IPC: A61K9/20
Filed: 1997-02-19
Abstract: A solid non-effervescent compressed dosage form comprising an ibuprofen combined with a disintegrating component wherein the ibuprofen medicament is present to a an extent of 35% or more by weight of the dosage form, characterised in that the carrier material further includes an alkali metal carbonate or bicarbonate in an amount such that the dosage form has a crushing strength in the range 6.5-15Kp and a disintegration time of less than 10 minutes. Such rapidly disintegrating compositions are particularly valuable in the treatment of pain and fever
Patent PT-925233-E (PT)
Inventor: HUNT RAYMOND JOHN
IPC: B65D85/66
Filed: 1997-09-08
Abstract: An edge protector for the edges of roll shaped articles, e.g. pallets, reeled steel and paper products is made from an elongated sheet (10) of plastics material, the sheet having an indentation (11) extending longitudinally along a major surface of the sheet and extending only partially into the thickness of the sheet. The indentation (11) divides the sheet into webs (12, 13) which are folded into an L-shape.
Patent PT-1032415-E (PT)
Inventor: GARROD DAVID RONALD
IPC: A61P11/02
Filed: 1998-12-11
Abstract: The present invention relates to the use of an inhibitor of cysteine proteinase activity in conjunction with an inhibitor of any serine proteinase activity other than trypsin for the manufacture of a medicament for the prevention or treatment of a condition in which an allergen traverses an epithelial barrier such as asthma. Also included in the invention are formulations and kits containing serine and cysteine proteinase inhibitors and their use in the prevention or treatment of conditions in which an allergen traverses an epithelial barrier.
Patent PT-1004557-E (PT)
Inventor: REINHARD UMLAUF DR
IPC: C09K17/44
Filed: 1999-09-06
Abstract: Hydraulic injection binder composition contains a hydraulic ground fine binder free from sulfate carrier, a solidification delaying agent, a fluxing agent, and a stabilizer selected from the group of microbial polysaccharides.
Patent PT-1106769-E (PT)
Inventor: SCHMIDT MICHAEL E
IPC: E05G1/024
Filed: 1999-12-10
Abstract: A fire protection storage safe, for documents etc. has several concentric walls with the spaces packed with a thermal barrier material. This is a thermal absorbing salt with a binder, e.g. vermiculite. The safe has an outer steel shell (2) several millimetres thick and an inner shell (6) of hard plastic or metal. An intermediate wall (3) of hard plastic or steel, can be perforated, and separates an outer vermiculite packing (54) from an inner packing which is a mixture of salt and binder. The salt undergoes a phase change when heated over long periods, and thereby absorbs a large amount of thermal energy.
Patent PT-983728-E (PT)
Inventor: CRISINEL PASCAL
IPC: A23B7/158
Filed: 1999-08-06
Abstract: The apparatus to process foodstuffs with a water enriched with ozone, by washing, has at least two reserves of an initial solution (41), a supply (22) of a gas mixture containing ozone, a station (23) where ozone is added to a fresh water supply and an injection system (25,L1-L3) to feed the water with ozone into each reserve. The injection system has at least two control units (27) to determine the vols. fed into the reserves. The dissolved ozone content in the water flow is equal to or greater than the highest ozone content in the reserves. A monitor system (46,47) registers the ozone content at each reserve to be passed to a data processing unit (26) for comparison of the ozone level at each reserve. Deviations are corrected by the feed controls (27), to maintain the required ozone content level, through command signals (28) from the data processing station (26). A buffer store (25) can be supplied with water containing ozone, with outlet lines (L1-L3) to the reserves (41), each with a flow control (27). At least one of the reserves has a secondary feed line (21b) of additional water as an independent feed, or into the ozone water supply downstream of the control point. The ozone water at the reserve is recirculated in its own circuit, including another reserve, or in a circuit containing the primary supply (21) and the ozone treatment station (23). A filter is in the recirculation for the water from the reserve and also for water with ozone, before it reaches the main supply point in the circuit. The system to apply ozone to the water can have a buffer store, for the ozone action, fed from the main supply and with outlet lines to the reserves through control points. The ozone treatment buffer has an inner porous diffuser, to deliver the processing gas, and a closed loop where ozone can be dissolved in the water flow. At least one of the reserves is fitted with an injection system, to deliver ozone into the stored water. An Independent claim is included for a water processing operation, where ozone is introduced into it. The water with ozone is held in reserves, and a water flow to the reserves is treated with ozone to be dissolved in it. Preferred Features: The water with ozone is passed to a buffer store, to be distributed to the reserves, with controlled feed flows. The water level is monitored at each reserve to determine the main feed of water containing ozone and a secondary feed.
Patent SG-75186-G (SG)
Title: Pulsed thyristor trigger control circuit
IPC: G05F1/70
Filed: 1986-09-17
Abstract: A trigger control circuit is provided for producing firing pulses for the thyristor of thyristor control system such as a power factor controller. The control circuit overcomes thyristor triggering problems involved with the current lag associated with controlling inductive loads and utilizes a phase difference signal, already present in the power factor controller, in deriving a signal for inhibiting generation of a firing pulse until no load current is flowing from the preceding half cycle and thereby ensuring that the thyristor is triggered on during each half cycle.
Patent IE-31945-L (IE)
Title: Carbamates of pyridine-methanol
IPC: C07D213/82
Filed: 1968-01-26
Abstract: 1,200,199. Hydroxymethylpyridine carbamates. T. SHIMAMOTO, M. ISHIKAWA, H. ISHIKAWA, M. INOLLE, and T. SHIMAMOTO. 26 Oct., 1967 [16 Feb., 1967; 17 April, 1967], No. 48795/67. Heading C2C. Novel hydroxymethylpyridine carbamates of the formula wherein R 1 and R 2 each represent H 1 alkyl, phenyl or benzyl, or R 1 and R 2 together form a divalent radical; R 3 is alkyl, OH, alkoxy, NH 2 , alkylamino, or dialkylamino, and the group -CH 2 O.CO.N(R 1 )R 2 is in the 2- or 6- position are prepared by reacting the corresponding 2- or 6-aryloxycarbonyloxymethylpyridine derivative with ammonia or an amine of the formula HN(R 1 )R 2 , or, for compounds of the above general formula in which R 1 is hydrogen and R 2 is alkyl, phenyl or benzyl, by reacting the appropriate 2- or 6-hydroxymethylpyridine with an alkyl phenyl or benzyl isocyanate or with compounds which can be converted to such an isocyanate under the reaction conditions, with, if necessary, a catalyst to promote such conversions. 2 - Phenoxycarbonyloxymethyl - 5 - ethoxycarbonylpyridine and 2 - (p - bromophenoxycarbonyloxy) - methyl - 5 - ethoxycarbonylpyridine are made by reacting 2-hydroxymethylpyridine with phenyl chloroformate and p-bromophenyl chloroformate respectively. Therapeutic compositions, having anti-inflammatory activity and suitable for oral administration, contain the above novel carbamates as the active ingredients and pharmaceutically acceptable carrier or diluents.
[GB1200199A]
Patent IE-870215-L (IE)
Title: Spool for inked ribbon of high speed printer
IPC: G03B21/32
Filed: 1987-01-28
Abstract: An inked ribbon spool 1 for a printer comprises a drum 2 having a bore 4 for reception of an idler spindle. Flanges 6 are provided on each side of the drum 2 and an annular internal involute bear 10 driven by a pinion 17. The gear drive mechanism allows a positive rotation of the spool 1 to be accurately controlled with low torque for controlled acceleration and deceleration. A ribbon is secured to the spool by engaging a fixing barb 15 in a transverse slot 11 in the drum and/or by engaging a ball shot in a square hole 24 in the drum 2.
Patent IE-810555-L (IE)
Title: Shrinkable split tows of acrylonitrile polymers
IPC: D01G1/08
Filed: 1981-03-13
Abstract: High-shrinkage stretch-broken tows of acrylonitrile polymers are obtained by fixing with saturated steam at maximum temperatures of 140 DEG  C. after drawing and before stretch breaking and stretch breaking at a draft of at least 30%.
Patent IE-790680-L (IE)
Title: Manufacture of a composite covering
IPC: B44C3/04
Filed: 1979-08-08
Abstract: Textured sheet material is produced by a process which includes two printing steps and two separate applications of plastisol in the form of discontinuous layers. The plastisol layers are applied over respective of the printed patterns and the first layer of plastisol is gelled, but not fused, prior to the second printing step which provides an image thereon. The process enables production of a relief pattern having "valleys" of two different depths.
[US4247353A]
Patent IE-790706-L (IE)
Title: Process for producing urea
IPC: C07C239/00
Filed: 1979-08-08
Abstract: Urea is produced form a gaseous mixture of H2, N2 and CO2, e.g. that obtained by the steam reforming of hydrocarbons. Carbon dioxide is absorbed from the mixture by the action, firstly, of an aqueous ammonia solution (e.g. above 70% by weight) and, secondly, of an ammonia-containing solution of ammonium carbonate, a solution of ammonium carbamate thus being obtained, together with a gaseous stream of nitrogen and hydrogen. The carbamate solution is passed to a urea reactor to obtain a urea solution containing unconverted carbamate and excess ammonia. The carbamate is decomposed and the evolved ammonia is recycled to the urea reactor along with carbon dioxide. The urea solution, now containing a reduced amount of carbamate (e.g. 50% of its original content), is passed to an adiabatic stripper in which the stripping gas used comprises hydrogen and nitrogen obtained from the CO2-absorption stage. Decomposition products together with water are removed from the adiabatic stripper, and are condensed in the presence of ammoniacal ammonium carbonate and the condensate so obtained is passed to the CO2-absorption step. <IMAGE>
[GB2018249A]
Patent IE-870847-L (IE)
Title: Fungicides
IPC: C07D239/10
Filed: 1987-04-01
Abstract: This invention relates to derivatives of acrylic acid useful in agriculture (especially as fungicides but also as plant growth regulators, insecticides and nematocides), to processes for preparing them, to agricultural (especially fungicidal) compositions containing them, and to methods of using them to combat fungi, especially fungal infections in plants, to regulate plant growth and to kill or control insect or nematode pests. The invention provides a compound having the formula (I): <IMAGE> (I) and stereoisomers thereof, wherein W is a substituted pyridinyl or substituted pyrimidinyl group linked to A by any of its ring carbon atoms; A is either an oxygen atom or S(O)n wherein n is 0, 1 or 2; X, Y and Z, which are the same or different, are hydrogen or halogen atoms, or hydroxy, optionally substituted alkyl (including haloalkyl), optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy.
[US5470819A]
Patent IE-820877-L (IE)
Title: Separating mercury from gases.
IPC: B01D53/34
Filed: 1982-04-14
Abstract: The invention relates to a method for separating gaseous elementary mercury from a gas in conjunction with a wet-gas cleaning process comprising a plurality of washing stages. The mercury-containing gas is treated with an aqueous washing liquid conducted in a closed circuit, the liquid containing 0.1-300 mmol/1 mercury (II) ions and at least twice this amount of ions having the ability of forming complexes with mercury (II) ions, the mercury in the gas being oxidized and absorbed in the washing liquid. The invention is characterized in that the treatment process is carried out in conjunction with a gas-cooling process effected after the last washing stage of the wet-gas cleaning process, to form a condensate for absorbing the halogens contained in the gas. The resultant condensate is transferred to the washing liquid and the mercury (II) content of the washing liquid is maintained by contacting the washing liquid with an oxidizing agent for mercury (I) ions. The agent used to oxidize mercury (I) ions is preferably chlorine gas.
[SE8102898L]
Patent IE-830920-L (IE)
Title: Preparation of labetalol.
IPC: C07C237/30
Filed: 1983-04-22
Abstract: There are disclosed a process for producing (-)-5-{(R)-1-hydroxy-2-[(R)-1-methyl-3-phenylpropyl]aminoethyl} salicylamide and its acid addition salts in high yields which does not require chromatography, and important intermediates in this process. <??>The process is stereoselective for the desired (R,R) amine; a preferred embodiment includes the steps of (1) reaction of an N-[(R)-protected]-(R)-1-methyl-3-phenylpropylamine with a 4-O-protected 2-bromo-3-carbamoylacetophenone to produce the corresponding R,R-glycylbenzamide, (2) reduction to produce a mixture of S,R,R;R,R,R-hydroxybenzamides, (3) removal of the protecting groups, (4) resolution of the deprotected product and, if desired, conversion to the free R,R -amine or to another salt. <??>In this process, the selection of particular N-protecting groups has a very favourable effect, especialy in steps (2) and (3). 
[EP0092787A1]
Patent IE-820951-L (IE)
Title: Clavulanic acid derivatives
IPC: H04Q11/08
Filed: 1982-04-22
Abstract: A time slot interchanger is disclosed for selecting and buffering digital signals between buses. The arrangement is particularly useful in forming conferences in a distributed digital time division system. In one embodiment, a clock is used to generate time signals corresponding to time slots of the first bus. These signals are sequentially provided to an associative memory and when a match occurs between the provided signal and a priorly stored time slot identity, an enable signal is provided. The enable signal has a time identity with a first bus time slot and a physical identity with a particular second bus time slot. The enable signal is used to gate into a second memory the time slot signal associated with the time identity at the storage location in the second memory corresponding with the particular time slot of the second bus associated with the enable signal. The signal samples are then sequentially removed from the second memory.
[US4382295A]